Prapela, Inc.

Concord,  MA 
United States
  • Booth: 441

Come meet a $1M award winner in the Ohio Opioid Technology Challenge!  Prapela, Inc. is introducing medical and consumer products based on its patented Stochastic Vibrotactile Stimulation (SVS) technology.  SVS is a gentle, random vibration that boosts healthy, rhythmic breathing, and heart rates helping babies relax. SVS is non-habit forming and does not interrupt sleep cycles. Clinically proven to help preterm infants and opioid-exposed newborns, the company has won more than $1,750,000 in awards and grants. The company's first product, the Prapela SVS baby box, was released on Father's Day, 2019. For more information, please visit

For technical assistance with this webpage, please contact support